top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant chemotherapy
androgen receptor
BCG therapy
biomarker
biomarkers
BIRC5
bladder
bladder cancer
bladder cancer detection
cadmium exposure
cancer
chemotherapy
combination therapy
DNA methylation
drug resistance
ECRG4
ERBB2
F-actin
FGFR3
grade
heparan sulfate proteoglycans (HSPGs)
heparanase
histone demethylase
immunotherapy
invasion
ITIH5
JAK inhibitor
JAK-STAT pathway
KDM7A
KRT20
macrophage
metabolomics
Metallothionein
MIBC
miRNA
MS
muscle-invasive bladder cancer
n/a
NMR
non muscle invasive bladder cancer
non-invasive detection
oncolytic adenovirus
p53
personalized medicine
prediction
predictive biomarker
prognosis
proliferation
PTEN
quantitative PCR
RT-qPCR
somatic mutations
STAT3/5 inhibitor
survival
survivin
syndecan-1
TAGLN
TC-E 5002
telomerase
TERT promoter mutations
TERT promoter region
tumor marker
tumor markers
tumorigenesis
urinary biomarkers
urothelial cancer
urothelial carcinoma
urothelium
virotherapy
voided urine cytology
XVir-N-31
zinc transporter
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Integrating Clinical and Translational Research Networks-Building Team Medicine
Integrating Clinical and Translational Research Networks-Building Team Medicine
Autore Salgia Ravi
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (250 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato academic and community oncology
academic cancer center
actionable mutations
adjuvant chemotherapy
bladder cancer
breast cancer
cancer care plans
cancer center
cancer clinical trials
cancer genetics
cancer genomics
cancer prevention
clinical research
clinical trials
colorectal cancer
community
community oncology
community practice
concurrent chemoradiation therapy
COVID-19
driver mutations
Early Recovery After Surgery (ERAS)
epithelial ovarian cancer
ethnicity
fast-and-frugal trees
feeding tube dependency
frontline treatment
genetics counseling
geriatric oncology
HER2-directed therapy
human papillomavirus
immunotherapy
integrated cancer care
low-dose CT scans
lung cancer
lung cancer screening
maintenance therapy
minorities
n/a
national guidelines for screening and prevention
next-generation sequencing
non-small cell lung cancer
older adults
oncology medical home
oncology pathways
oropharyngeal cancer
PARP inhibitor
personalized medicine
pharmaceutical aids to smoking cessation
precisian medicine
precision medicine
race
receptor tyrosine kinases
recruitment
renal cell carcinoma
research
small cell lung cancer
smoking cessation
supportive care pathways
surgical debulking
surgical pathways
team medicine
team science
team-based care
team-based medicine
testing rates
tobacco control
translational research
urothelial carcinoma
value-based cancer care
value-based care
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557124403321
Salgia Ravi  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Outcomes and Therapeutic Management of Bladder Cancer
Outcomes and Therapeutic Management of Bladder Cancer
Autore Moschini Marco
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (120 p.)
Soggetto topico Medicine
Soggetto non controllato adjuvant
age
anesthesia recovery periods
biomarkers
bladder cancer
chemotherapy
clear-cell adenocarcinoma
cognitive impairment
female
FOXA1
gamma-cyclodextrins
GATA3
glycogen
human epidermal growth factor receptor 2
immunotherapy
indoleamine 2,3-dioxygenase
intracorporeal neobladder
KRT20
methylation
molecular markers
mRNA
muscle-invasive bladder cancer
n/a
neoadjuvant
neuromuscular blockade
nodal disease
open
outcome
outcomes
PCR
pN1
programmed death ligand-1
propensity score
radical cystectomy
robotic
robotic radical cystectomy
robotic-assisted
SEER program database
sex-sparing
survival
urinary bladder
urothelial carcinoma
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114503321
Moschini Marco  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers
Role of Medical Imaging in Cancers
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (312 p.)
Soggetto topico Medicine
Soggetto non controllato 18F-FACBC
18F-FDG PET/CT
68Gallium-PSMA PET/CT
adipose tissue
Adoptive
biochemical recurrence
biomarker
biomarkers
bladder cancer
breast
breast cancer
castrate resistant prostate cancer
CD8-Positive T-Lymphocytes
circulating miRNAs
circulating tumor cells
computed tomography
Computer-assisted diagnosis
concurrent chemoradiotherapy
consensus
CTLA-4 Antigen
cystic tumor
DCFBC
DCFPyL
Deauville criteria
diagnosis
diagnostic imaging
diffuse large B-cell lymphoma
diffusion
diffusion kurtosis imaging
diffusion tensor imaging
diffusion-weighted imaging
dynamic 18F-FDG PET/CT
dynamic contrast-enhanced magnetic resonance imaging
EBV
empyema
epistemology
FDG
FDG-PET/CT
follow up
glioblastoma
gold nanoparticle
guidelines
head and neck cancer
head and neck neoplasms
heat shock protein 70
Hodgkin lymphoma
Hounsfield unit
HPV
imaging
imaging parameters
immune checkpoint inhibitors
immunotherapy
Immunotherapy
International Consensus Guidelines
intraductal papillary mucinous neoplasms
locally advanced cervical cancer
machine learning
magnetic resonance imaging
malignant pleural mesothelioma
mantle cell lymphoma
marker
mCRPC
meningioma
Mesothelin
meta-analysis
metastatic breast cancer
miRNA expression
molecular imaging
Molecular imaging
MRI
n/a
neovascularization
neuroimaging
non-small-cell lung cancer
noninvasive imaging
NSCLC
nuclear medicine
optimal cutoff level
ovarian cancer
overutilization
p16
pancreatic neoplasms
pathologic
pazopanib
PD-1
PD-L1
PDAC
PERCIST
perfusion
PET
PET/CT
PET/MRI
PI-RADS
pleural dissemination
pleural effusion
positron emission tomography
positron-emission tomography
precision oncology
prognosis
programmed cell death 1 receptor
prostate
prostate cancer
prostate-specific-antigen
PSA kinetics thresholds
PSMA
PSMA-1007
radiation therapy
radioactive tracers
radiogenomics
radiomic
radiomics
radionuclide imaging
radionuclide therapy
Radium-223
receptor status
recurrence
relapse
response assessment
response to therapy
response to treatment
review
sdAbs
single-photon emission computed tomography
soft tissue sarcoma (STS)
somatostatin receptor
SPECT imaging
SPECT/CT
spectral-CT
squamous cell carcinoma of the head and neck
staging
survival
SUV
SUVmax
targeted therapy
texture analysis
Therapy response assessment
treatment response
triple negative breast cancer
two-tissue compartment model
upper tract urothelial carcinoma
urothelial carcinoma
VCAM-1
XOFIGO
Yin Yang 1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557432103321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Role of Medical Imaging in Cancers
Role of Medical Imaging in Cancers
Autore Fanti Stefano
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (228 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato 18F-FACBC
18F-FDG PET/CT
68Gallium-PSMA PET/CT
adipose tissue
Adoptive
biochemical recurrence
biomarker
biomarkers
bladder cancer
breast
breast cancer
castrate resistant prostate cancer
CD8-Positive T-Lymphocytes
circulating miRNAs
circulating tumor cells
computed tomography
Computer-assisted diagnosis
concurrent chemoradiotherapy
consensus
CTLA-4 Antigen
cystic tumor
DCFBC
DCFPyL
Deauville criteria
diagnosis
diagnostic imaging
diffuse large B-cell lymphoma
diffusion
diffusion kurtosis imaging
diffusion tensor imaging
diffusion-weighted imaging
dynamic 18F-FDG PET/CT
dynamic contrast-enhanced magnetic resonance imaging
EBV
empyema
epistemology
FDG
FDG-PET/CT
follow up
glioblastoma
gold nanoparticle
guidelines
head and neck cancer
head and neck neoplasms
heat shock protein 70
Hodgkin lymphoma
Hounsfield unit
HPV
imaging
imaging parameters
immune checkpoint inhibitors
immunotherapy
Immunotherapy
International Consensus Guidelines
intraductal papillary mucinous neoplasms
locally advanced cervical cancer
machine learning
magnetic resonance imaging
malignant pleural mesothelioma
mantle cell lymphoma
marker
mCRPC
meningioma
Mesothelin
meta-analysis
metastatic breast cancer
miRNA expression
molecular imaging
Molecular imaging
MRI
n/a
neovascularization
neuroimaging
non-small-cell lung cancer
noninvasive imaging
NSCLC
nuclear medicine
optimal cutoff level
ovarian cancer
overutilization
p16
pancreatic neoplasms
pathologic
pazopanib
PD-1
PD-L1
PDAC
PERCIST
perfusion
PET
PET/CT
PET/MRI
PI-RADS
pleural dissemination
pleural effusion
positron emission tomography
positron-emission tomography
precision oncology
prognosis
programmed cell death 1 receptor
prostate
prostate cancer
prostate-specific-antigen
PSA kinetics thresholds
PSMA
PSMA-1007
radiation therapy
radioactive tracers
radiogenomics
radiomic
radiomics
radionuclide imaging
radionuclide therapy
Radium-223
receptor status
recurrence
relapse
response assessment
response to therapy
response to treatment
review
sdAbs
single-photon emission computed tomography
soft tissue sarcoma (STS)
somatostatin receptor
SPECT imaging
SPECT/CT
spectral-CT
squamous cell carcinoma of the head and neck
staging
survival
SUV
SUVmax
targeted therapy
texture analysis
Therapy response assessment
treatment response
triple negative breast cancer
two-tissue compartment model
upper tract urothelial carcinoma
urothelial carcinoma
VCAM-1
XOFIGO
Yin Yang 1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557309503321
Fanti Stefano  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2020
Urological Cancer 2020
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 online resource (334 p.)
Soggetto topico Biology, life sciences
Research & information: general
Soggetto non controllato [68Ga]Ga-PSMA PET/CT
androgen receptor
androgen response
angiogenesis
angiogenic growth factors
anoikis
antiangiogenic therapy
artificial intelligence
biomarker
biphasic imaging
bladder cancer
cell proliferation
chelation therapy
CPT1A
CXCL9
deep learning
delayed imaging
diagnosis
differential diagnosis
DONSON
Downstream Neighbor of SON
dual-time point imaging
en-bloc resection
fatty acids
histopathology
immunohistochemistry
iron
KLF5
lesion positivity rate
machine learning
macrophages
MAP1B
metastatic spread
microtubule
MR-guided
MRgRT
n/a
neural network
oncogenes
online adaptive
optical mapping
oxidative stress
patient-derived xenografts
PD-L1
PD1
precision medicine
prevention
prognosis
prostate cancer
prostate carcinoma
prostate mpMRI
prostatic neoplasms/epidemiology
prostatic neoplasms/mortality
radiotherapy
RCC
renal cell cancer
renal cell carcinoma
renal tumors
research model
ROS
SEER Program
serine
stage T1 NMIBC
stereotactic ablative radiation therapy (SABR)
stereotactic ablative radiotherapy
stroma signature
therapy
transcriptome
transurethral resection
tumor suppressor genes
tumorigenesis
urothelial carcinoma
vascularity
whole genome sequencing
α1-adrenoceptor antagonists
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557354903321
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Urological Cancer 2021
Urological Cancer 2021
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (328 p.)
Soggetto topico Chemistry
Research & information: general
Soggetto non controllato 177Lu-PSMA
abiraterone
ablation margins
advanced urothelial carcinoma
AHNAK2
autopsy
Bacillus Calmette-Guérin (BCG)
biomarker
biomarkers
biopsy
bladder cancer
bladder cancer cell lines
bladder carcinoma
cancer
cell migration
comparative effectiveness
comparative oncology
ctDNA
decision making
diagnosis
divergent differentiation
docetaxel
dog
enzalutamide
epiplakin
epithelial-mesenchymal transition
fluorescence confocal microscopy
focal therapy
frail patients
frailty
FTY-720
game theory
genomic analysis
genomic signatures
glutaminase
Hounsfield units
image-guided
immune checkpoint inhibitor
immune checkpoint inhibitors
immunohistochemistry
immunotherapy
in situ methods
inflammation
inflammatory indices
latent cancer
liquid biopsy
machine learning
magnetic resonance imaging
mCRPC
metastasectomy
metastasis
metastatic prostate cancer
microenvironment
molecular subtypes
mortality
n/a
novel hormonal therapies
OIP5
oncological outcomes
papillary renal cell carcinoma
PD-1
PD-L1
PLK1
positron-emission tomography
postoperative complications
preclinical studies
prediction model
preneoplastic lesion
prognosis
prognostic
prognostic factor
prognostic index
prostate
prostate biopsy
prostate cancer
prostatic atrophy
prostatic neoplasms
PSA
PSMA-RLT
psoas muscle
radical cystectomy
radiosensitisation
radiotherapy
real-world treatment pattern
renal cell carcinoma
screening trial
sphingosine 1-phosphate receptor 1
stereotactic body radiotherapy
survival
therapy
TRIPOD
tumor ecology
tumor thrombus
tumorigenesis
tumour mutational board
ultrasonography
urinary bladder neoplasms
urine
urothelial carcinoma
variant morphology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576872803321
MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui